[go: up one dir, main page]

GR990100331A - Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses - Google Patents

Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses

Info

Publication number
GR990100331A
GR990100331A GR990100331A GR990100331A GR990100331A GR 990100331 A GR990100331 A GR 990100331A GR 990100331 A GR990100331 A GR 990100331A GR 990100331 A GR990100331 A GR 990100331A GR 990100331 A GR990100331 A GR 990100331A
Authority
GR
Greece
Prior art keywords
cells
genetic
amniotic
embryo
human
Prior art date
Application number
GR990100331A
Other languages
Greek (el)
Other versions
GR1004204B (en
Inventor
Original Assignee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by filed Critical
Publication of GR990100331A publication Critical patent/GR990100331A/en
Publication of GR1004204B publication Critical patent/GR1004204B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

This invenion belongs to the field of biotechnology, cryobiology and human therapeutics. Object of the invention are a) amniotic cells originating from amniotic fluid that surrounds the embryo in its early development stages, b) amniotic cells that at early embryonic stage are floating within the human embryo-clone, c) every biological material which will be created directly of idirectly from the above amniotic cells, as well as every biological product or byproduct which will be the outcome of the use of the said cryopreserved amniotic cells, through their reproduction on multiplication under the same or any other modified form and which will possess the same genetic properties and applications.These amniotic cells are isolated from their natural environment and preserved in deep-freezing for very long periods of time after their own natural life span, which is short within their natural environment, that is within the amniotic fluid and within the embryo-clone. The purpose is the genetic and medical use of these cells at a time posterior to their natural destruction. In this way, we succeed to use primal, undifferentiated, genetically identical cells of each human being for diagnosis and therapy of genetic or non-genetic diseases, malfunctions and accidents, where these are known today or shall be applied in the future.
GR990100331A 1999-09-29 1999-09-29 Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses GR1004204B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR99100331 1999-09-29

Publications (2)

Publication Number Publication Date
GR990100331A true GR990100331A (en) 2001-05-31
GR1004204B GR1004204B (en) 2003-09-05

Family

ID=10943929

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990100331A GR1004204B (en) 1999-09-29 1999-09-29 Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses

Country Status (3)

Country Link
AU (1) AU7437900A (en)
GR (1) GR1004204B (en)
WO (1) WO2001023532A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265281A1 (en) * 2003-04-07 2004-12-30 Denis Rodgerson System capable of treating and defining various diseases using stem cells
US20050042595A1 (en) 2003-08-14 2005-02-24 Martin Haas Banking of multipotent amniotic fetal stem cells
US8196416B2 (en) 2004-02-02 2012-06-12 Core Dynamics Limited Device for directional cooling of biological matter
WO2005072523A2 (en) 2004-02-02 2005-08-11 I.M.T. Interface Multigrad Technology Ltd. Biological material and methods and solutions for preservation thereof
US7892726B2 (en) 2004-06-07 2011-02-22 Core Dynamics Limited Method for sterilizing lyophilized eukaryotic anuclear cells with gamma irradiation
WO2006016372A1 (en) 2004-08-12 2006-02-16 I.M.T. Interface Multigrad Technology Ltd. Method and apparatus for freezing or thawing of a biological material
WO2007015252A2 (en) 2005-08-03 2007-02-08 I.M.T. Interface Multigrad Technology Ltd. Somatic cells for use in cell therapy
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
CA3177726A1 (en) 2015-05-21 2016-11-24 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0333328A2 (en) * 1988-02-17 1989-09-20 Genethics Limited Clinical developments using amniotic cells
WO1997035472A1 (en) * 1996-03-25 1997-10-02 Advanced Reproduction Technologies, Inc. Use of arabinogalactan in cell cryopreservation media
US5879937A (en) * 1994-01-12 1999-03-09 Schering Corporation Cytokine-induced proliferation of amniotic t-cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4072203B2 (en) * 1996-01-23 2008-04-09 株式会社エスアールエル Dementia treatment cells
AU4860900A (en) * 1999-06-02 2000-12-18 Lifebank Services, L.L.C. Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0333328A2 (en) * 1988-02-17 1989-09-20 Genethics Limited Clinical developments using amniotic cells
US5879937A (en) * 1994-01-12 1999-03-09 Schering Corporation Cytokine-induced proliferation of amniotic t-cells
WO1997035472A1 (en) * 1996-03-25 1997-10-02 Advanced Reproduction Technologies, Inc. Use of arabinogalactan in cell cryopreservation media

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ETZIONI A: "Amniocentesis: A case study in the management of 'genetic engineering'.", ETHICS IN SCIENCE AND MEDICINE, vol. 2, no. 1, May 1975 (1975-05-01), pages 13 - 24, XP000923008 *

Also Published As

Publication number Publication date
GR1004204B (en) 2003-09-05
AU7437900A (en) 2001-04-30
WO2001023532A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
Kook et al. Involvement of JNK-AP-1 and ERK-NF-κB signaling in tension-stimulated expression of type I collagen and MMP-1 in human periodontal ligament fibroblasts
Chang et al. Effects of calcium silicate endodontic cements on biocompatibility and mineralization-inducing potentials in human dental pulp cells
Nettelhoff et al. Influence of mechanical compression on human periodontal ligament fibroblasts and osteoblasts
Sowmya et al. Buffalo milk casein derived decapeptide (YQEPVLGPVR) having bifunctional anti-inflammatory and antioxidative features under cellular milieu
TR201903587T4 (en) Compounds for increasing telomerase activity.
GR990100331A (en) Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses
El Alami et al. Activation of p38, p21, and NRF-2 mediates decreased proliferation of human dental pulp stem cells cultured under 21% O2
Cheng et al. Impact of maturational status on the ability of osteoblasts to enhance the hematopoietic function of stem and progenitor cells
WO2003042661A8 (en) Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
CA2338541A1 (en) Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy
NO20070854L (en) Human monoclonal antibodies to human IL-4.
Charoenpong et al. Mechanical stress induced S100A7 expression in human dental pulp cells to augment osteoclast differentiation
Di Francesco et al. Effect of allogeneic oral mucosa mesenchymal stromal cells on equine wound repair
Choi et al. Milk activates the expression of cytokines via N rf2/HO‐1 pathway in human periodontal ligament cells
Gutiérrez-Venegas et al. The flavonoids luteolin and quercetagetin inhibit lipoteichoic acid actions on H9c2 cardiomyocytes
KR102167819B1 (en) Pharmaceutical composition for preventing or treating rheumatoid arthritis, comprising nasal inferior turbinate derived mesenchymal stem cell as an active ingredient
Zhu et al. Gene expression of sHsps, Hsp40 and Hsp60 families in normal and abnormal embryonic development of mouse forelimbs
Yang et al. Interleukin‐15 inhibits sodium nitroprusside–induced apoptosis of synovial fibroblasts and vascular endothelial cells
Chitte et al. The world of proteases across microbes, insects, and medicinal trees
Rafat et al. Bone marrow CD34 positive cells may be suitable for collection after death
Maryam Mirghiasi et al. The effect of Malva neglecta on the reduction of inflammatory agents in patients with osteoarthritis
KR102188572B1 (en) Formulation for injection of stem cells containing cerebrospinal fluid and method for production
DE60130775D1 (en) STIMULATION OF THE NEUTROPHIL FUNCTION FOR THE TREATMENT OF INFLAMMATORY ENDURANCE DISEASES
Kannan et al. Evaluation of Tualang honey as a supplement to fetal bovine serum in cell culture
ATE239749T1 (en) PHOSPHORUS-CONTAINING DENDRIMERS AS TRANSFECTION AGENT

Legal Events

Date Code Title Description
PG Patent granted
ML Lapse due to non-payment of fees

Effective date: 20120403